期刊文献+

帕瑞昔布在膝关节镜术后镇痛中的应用 被引量:2

Application of parecoxib for postoperative analgesia in arthroscopic surgery of the knee
原文传递
导出
摘要 目的:探讨帕瑞昔布短期应用对膝关节镜手术患者术后镇痛的影响。方法:60例择期膝关节镜前交叉韧带重建术患者,ASAⅠ~Ⅱ级,年龄18~50岁,体重指数均在正常范围。随机分为3组:安慰剂组(Ⅰ组)、术前帕瑞昔布组(Ⅱ组)和术后帕瑞昔布组(Ⅲ组)。采用VAS评分测定静注帕瑞昔布后2,61,2和24 h时疼痛程度,并记录各时间点不良反应情况,以及患者对镇痛的总体满意度。结果:与Ⅰ组相比,Ⅱ、Ⅲ组术后61,2,24 h VAS评分降低,术后使用镇痛药例数显著减少,术后24 h患者满意度明显提高,不良反应发生率降低;而Ⅱ组在术后6和12 h时VAS评分较Ⅲ组低(P<0.05)。结论:静脉给予帕瑞昔布钠40 mg可减轻患者膝关节镜手术后疼痛,降低不良反应发生率,提高术后镇痛质量,术前使用较术后使用效果更佳。 Objective:To investigate effectiveness of parecoxib sodium for postoperative analgesia in arthroscopic surgery of the knee.Methods:In 60 patients(ASA I or II,aged 18~50 yr,scheduled for elective arthroscopic surgery of the knee) were randomly divided into three groups(n=20 for each group).Patients were intravenously injected with parecoxib sodium 40 mg before or at the end of surgery,or with equivalence saline(control).The intensity of pain was evaluated using VAS score(0~10,0=no pain,10=worst pain) at 2,6,12,24 h after operation.The adverse effects,the needs of postoperative analgesic drugs and the patients' global evaluation of the postoperative analgesia were recorded and compared 24 h after the operation.Results:As compared with control,parecoxib administered both before and after surgery significantly reduced the needs of postoperative analgesic drugs at 24 h,the VAS scores after operation,and the adverse effects(P0.05).Meanwhile,the patients in both parecoxib groups were more satisfied for the postoperative analgesia than those in control group(P0.05).The VAS scores at 6,12 h after operation were significantly less when parecoxib was injected at the end of surgery.Conclusion:Intravenous parecoxib sodium(40 mg) has a potent analgesic effect,reduces the percentage of adverse effects,and improves postoperative analgesic effect.Pre-operative application of parecoxib may be more effective.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第5期440-443,共4页 Chinese Journal of New Drugs
基金 贝朗麻醉科学研究基金(2009年度)
关键词 帕瑞昔布 膝关节镜手术 镇痛 parecoxib arthroscopic surgery of the knee analgesia
  • 相关文献

参考文献10

  • 1VISCUSI ER, GIMBEL JS, HALDER AM, et al. A muhiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty [ J ]. Anesth Analg, 2008, 107 ( 2 ) : 652 - 660.
  • 2SOLTESZ S, GERBERSHAGEN MU, PANTKE B, et al. Parecoxib versus dipyrone (metamizole) for postoperative pain relief after hysterectomy: a prospective, single-centre, randomized, double-blind trial [ J ]. Clin Drug lnvestig, 2008,28 ( 7 ) : 421 - 428.
  • 3DAHL JB, MOINICHE S. Preemptive analgesia[ J]. Br Med Bull,2004,71 ( 1 ) : 13 - 27.
  • 4SOLCA M. Acute pain management: unmet needs and new advances in pain management[ J]. Eur J Anaesthesiol Suppl, 2002, 25(1) :3 -10.
  • 5ARDOIN SP, SUNDY JS. Update on nonsteriodal anti-inflammatory drugs [ J ]. Cttrr Opin Rheumatol,2006,18 ( 3 ) : 221 - 226.
  • 6REUBEN SS, EKMAN EF, RAGHUNATHAN K, et al effect of yclooxy genase-2 inhibition on acute and chronic site pain after spinal fusion surgery [ J ]. Reg Anesth Pain 2006, 31(1): 6-13, The donor Med ,.
  • 7COLANARDI MC, NETTIS E, TRAETTA PD, et al. Parecoxib as an alternative in COX-2 hypersensitivity [ J ]. lnt J lmmunopathol Pharmacol, 2008,21 ( 1 ) :233 -235.
  • 8吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 9RASMUSEEN GL, STECKNER K, HOGUE C, et al. Intravenous parecoxibsodium for acute pain after orthopedic knee surgery [J]. Am J Orthop,2002,31( 2 ) :336 - 343.
  • 10CHEER SM, GOA KL. Parecoxib ( parecoxib sodium ) [ J ]. Drugs, 2001,61 (8) :1133 -1141.

二级参考文献11

  • 1McArdle P. Intravenous analgesia. Crit Care Clin, 1999,15:89-104.
  • 2Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf, 1998,19:173-189.
  • 3Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia"in postoperative pain treatment. Anesth Analg, 1993,77:1048-1056.
  • 4Power I, Barrett S. Analgesic agents for the postoperative period: nonopioids. Surg Clin North Am, 1999,79:275-295.
  • 5Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am, 1999,79:401-430.
  • 6Lipsky LP, Abramson SB, Crefford L, et al. The classification of cyclooxygenase inhibitors. J Rheumatol, 1998,25:2298-2303.
  • 7Penning TD, Talley JJ, Berteushaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenuse-2 inhihitors:identification of 4- [ 5- ( 4-methylphenyl ) -3- ( trifluoremethyl )- 1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem, 1997,40:1347-1365.
  • 8Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenuse type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002,96: 1305-1309.
  • 9Malan TP Jr,Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenuse 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003,98 :950-956.
  • 10Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg, 2004,99:797-806.

共引文献366

同被引文献26

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部